Dynex Partners With The Binding Site To Provide Automated And Validated Systems For Autoimmune And Infectious-Disease Assays

Chelmsford, MA - Dynex Technologies, a Magellan Biosciences company, anounced an expanded relationship with The Binding Site to market Dynex's automated DSXTM "walk-away" workstation. The Binding Site Inc. of San Diego, California, a worldwide leader in immunodiagnostics, will combine its full range of ELISA kits and reagents along with exclusive 24/7 service and support as part of a complete laboratory solution for automation of autoimmune and infectious-disease assays.

"We are working hard to expand our presence in the clinical-diagnostic market, and this marketing-partnership agreement between Dynex and solutions partner, The Binding Site, is an important example," said Chief Executive Officer and President Dr. Robert J. Rosenthal. "We are also pursuing technology-licensing agreements, acquisitions, and building on our existing technology platforms to develop novel clinical-laboratory and point-of-care products."

"We're very pleased to continue our long-term relationship with The Binding Site as part of our strategy to partner with premier providers to expand the reach of our technologies and serve clinical customers better," said Dynex President Henry O'Connell. "We designed the DSX to be an open system so clinical laboratories can have the flexibility they need to run virtually any ELISA assay."

"Dynex's products have been an important part of our offerings to customers for the past five years," said The Binding Site's Vice President of Sales and Technical Services, Anne Grainger. "Now, through this expanded agreement we can better serve our customers with our entire range of autoimmune and infectious disease ELISA kits, and by providing the technical expertise to fully realize the potential of the DSX as an open-system platform. In addition, customers will receive exclusive 24/7 technical support through service partner Excalibur Lab Specialists."

SOURCE: Dynex Technologies